Allergen immunotherapy as add-on to biologic agents
Sign Up to like & getrecommendations! Published in 2018 at "Current Opinion in Allergy and Clinical Immunology"
DOI: 10.1097/aci.0000000000000479
Abstract: Purpose of review In this review, we sought to outline many of the recent evidences about the available clinical trials in which biologic agents [i.e. omalizumab (OMA)] were associated as add-on to allergen-specific immunotherapy (AIT).… read more here.
Keywords: immunotherapy add; immunotherapy; allergen immunotherapy; add biologic ... See more keywords